These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7343132)

  • 21. [Cryoglobulinemia and its significance in human African Trypanosoma brucei gambiense trypanosomiasis].
    Lurhuma AZ; Kageruka P; Henry MC; Mbayo K
    Ann Soc Belg Med Trop; 1978 Dec; 58(4):301-7. PubMed ID: 754654
    [No Abstract]   [Full Text] [Related]  

  • 22. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trypanosoma brucei gambiense. Antigenic study. II. Immunogenic fractions. Partial results].
    Fromentin H
    Bull Soc Pathol Exot Filiales; 1974; 67(3):281-4. PubMed ID: 4142866
    [No Abstract]   [Full Text] [Related]  

  • 24. [African trypanosomes have the sense of sacrifice].
    Pays E
    Med Sci (Paris); 2012 Oct; 28(10):817-9. PubMed ID: 23067409
    [No Abstract]   [Full Text] [Related]  

  • 25. Human African trypanosomiasis: presence of antibodies to galactocerebrosides.
    Amevigbe MD; Jauberteau-Marchan MO; Bouteille B; Doua F; Breton JC; Nicolas JA; Dumas M
    Am J Trop Med Hyg; 1992 Nov; 47(5):652-62. PubMed ID: 1449206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.
    Anthoons JA; Van Marck EA; Gigase PL
    Z Parasitenkd; 1986; 72(4):443-52. PubMed ID: 3529673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma brucei brucei: a model for cerebral trypanosomiasis in mice--an immunological, histological and electronmicroscopic study.
    Poltera AA; Hochmann A; Rudin W; Lambert PH
    Clin Exp Immunol; 1980 Jun; 40(3):496-507. PubMed ID: 6998617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines and anti-cytokine autoantibodies during experimental african trypanosomiasis in mice with disrupted interferon-gamma and interferon-gamma receptor genes.
    Eltayeb R; Mustafa M; Lycke N; van der Meide PH; Bakhiet M
    Int J Mol Med; 1998 Jan; 1(1):177-83. PubMed ID: 9852217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis.
    Amin DN; Rottenberg ME; Thomsen AR; Mumba D; Fenger C; Kristensson K; Büscher P; Finsen B; Masocha W
    J Infect Dis; 2009 Nov; 200(10):1556-65. PubMed ID: 19827943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of Cricetomys gambianus in the study of experimental trypanosomiasis from Trypanosoma gambiense. Methods for mass preparation of antigen and purification of serum exoantigen].
    Derouin F; Roffi J; Diallo PB; Dedet JP
    C R Seances Soc Biol Fil; 1978; 172(2):388-92. PubMed ID: 150933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterophile antibody to red cells in human trypanosomiasis.
    Parratt D; Cobb SJ
    Afr J Med Med Sci; 1978 Jun; 7(2):57-64. PubMed ID: 102137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human African trypanosomiasis: clinical presentation and immune response.
    Sternberg JM
    Parasite Immunol; 2004; 26(11-12):469-76. PubMed ID: 15771682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of Trypanosoma brucei, T. rhodesiense, and T. gambiense by the indirect fluorescent antibody test.
    Latif BM; Adam KM
    Bull World Health Organ; 1973; 48(4):401-7. PubMed ID: 4587481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of antibodies to IFN-gamma in human and experimental African trypanosomiasis.
    Bonfanti C; Caruso A; Bakhiet M; Olsson T; Turano A; Kristensson K
    Scand J Immunol; 1995 Jan; 41(1):49-52. PubMed ID: 7824888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the reactivity of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping sickness focus, Cameroon.
    Asonganyi T; Bedifeh BA; Ade SS; Ngu JL
    Afr J Med Med Sci; 1994 Mar; 23(1):39-46. PubMed ID: 7839945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic variation in African trypanosomiasis: a memorandum.
    Bull World Health Organ; 1977; 55(6):703-13. PubMed ID: 74295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrosyneresis in the diagnosis of African trypanosomiasis].
    Poupin F; Cailliez M; Petithory JC; Savel J
    Bull Soc Pathol Exot Filiales; 1976; 69(1):76-83. PubMed ID: 825237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis.
    Lambert PH; Berney M; Kazyumba G
    J Clin Invest; 1981 Jan; 67(1):77-85. PubMed ID: 6969733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The trypanolytic factor of human serum.
    Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
    Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.